Biosimilars for the treatment of patients with psoriasis: A consensus statement from the Biosimilar Working Group of the International Psoriasis CouncilCapsule Summary

Biosimilars for the treatment of patients with psoriasis: A consensus statement from the Biosimilar Working Group of the International Psoriasis CouncilCapsule Summary

Background: As biosimilars have become available in various parts of the world, the International Psoriasis Council has reviewed aspects of their use. Objective: To provide consensus statements from the Biosimilar Working Group about the use of biosimilars in patients with psoriasis. Methods: A semi...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Arnon D. Cohen, MD, MPH, PhD, Ronald Vender, MD, FRCPC, Luigi Naldi, MD, Robert E. Kalb, MD, Tiago Torres, MD, PhD, Murlidhar Rajagopalan, MD, Joelle van der Walt, PhD, Lluís Puig, MD (Hon), PhD, Helen S. Young, MB ChB, PhD, FRCP
التنسيق: مقال
اللغة:English
منشور في: Elsevier 2020-12-01
سلاسل:JAAD International
الموضوعات:
biosimilars
interchangeability
International Psoriasis Council
psoriasis
switching
tumor necrosis factor inhibitors
الوصول للمادة أونلاين:http://www.sciencedirect.com/science/article/pii/S2666328720300523

مواد مشابهة

مواد مشابهة